Activation of the purinergic receptor P2X7 improves hepatosteatosis by promoting lipophagy

9Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a global health problem that develops through unclear molecular mechanisms. The P2X7 purinergic receptor (P2RX7) is an ATP-gated ion channel that belongs to the P2XR family. Thus far, studies on P2RX7 in NAFLD have been largely contradictory. Integrating experiments and modeling, we elucidate the dynamic processes of lipid droplet fusion and degradation following regulation of P2RX7. We show that activation of P2RX7 can activate the AMPK/ULK1 pathway to promote autophagosome generation and lysosomal degradation of autophagosomes. Inhibiting P2RX7 has the opposite effect. Notably, we find that lipid droplets become larger by the fusion of dysfunctional lysosomes but cannot be degraded by them following P2RX7 inhibition. Our study provides evidence that P2RX7 activation improves NAFLD by promoting lipophagy.

Cite

CITATION STYLE

APA

Dong, Z., Wei, Y., Tao, M., & Zhang, L. (2021). Activation of the purinergic receptor P2X7 improves hepatosteatosis by promoting lipophagy. FEBS Letters, 595(22), 2768–2780. https://doi.org/10.1002/1873-3468.14207

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free